4810 related articles for article (PubMed ID: 4015040)
1. Effects of a calcium-antagonist (flunarizine) on cancer cell movement and phagocytosis.
Sezzi ML; De Luca G; Materazzi M; Bellelli L
Anticancer Res; 1985; 5(3):265-71. PubMed ID: 4015040
[TBL] [Abstract][Full Text] [Related]
2. Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.
Litton MJ; Dohlsten M; Hansson J; Rosendahl A; Ohlsson L; Kalland T; Andersson J; Andersson U
Am J Pathol; 1997 May; 150(5):1607-18. PubMed ID: 9137087
[TBL] [Abstract][Full Text] [Related]
3. Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro.
Price EA; Coombe DR; Murray JC
Int J Cancer; 1996 Feb; 65(4):513-8. PubMed ID: 8621236
[TBL] [Abstract][Full Text] [Related]
4. Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.
Lejeune F; Liénard D; Eggermont A; Schraffordt Koops H; Rosenkaimer F; Gérain J; Klaase J; Kroon B; Vanderveken J; Schmitz P
J Infus Chemother; 1995; 5(2):73-81. PubMed ID: 8521239
[TBL] [Abstract][Full Text] [Related]
5. MSH receptors and function in amelanotic B16 melanoma cells.
Lunec J; Pieron C; Bal W; MacNeil S; Thody AJ
Melanoma Res; 1993 Apr; 3(2):99-106. PubMed ID: 8390876
[TBL] [Abstract][Full Text] [Related]
6. Effect of penicillin-streptomycin and other antibiotics on melanogenic parameters in cultured B16/F10 melanoma cells.
Martínez-Liarte JH; Solano F; Lozano JA
Pigment Cell Res; 1995 Apr; 8(2):83-8. PubMed ID: 7659681
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy for nodal disease in malignant melanoma.
Burmeister BH; Smithers BM; Poulsen M; McLeod GR; Bryant G; Tripcony L; Thorpe C
World J Surg; 1995; 19(3):369-71. PubMed ID: 7638990
[TBL] [Abstract][Full Text] [Related]
8. The differential diagnosis of posterior uveal melanoma.
Shields JA; Augsburger JJ; Brown GC; Stephens RF
Ophthalmology; 1980 Jun; 87(6):518-22. PubMed ID: 7413140
[TBL] [Abstract][Full Text] [Related]
9. Uselessness of thermography for diagnosis and follow-up of cutaneous malignant melanoma.
Cristofolini M; Perani B; Piscioli F; Recchia G; Zumiani G
Tumori; 1981; 67(2):141-3. PubMed ID: 7256880
[TBL] [Abstract][Full Text] [Related]
10. Tyrosinase-mediated inhibition of in vitro leucine incorporation into mouse melanoma by 4-isopropylcatechol.
Sugano H; Sugano I; Jimbow K; Fitzpatrick TB
Cancer Res; 1975 Nov; 35(11 Pt 1):3126-30. PubMed ID: 810242
[TBL] [Abstract][Full Text] [Related]
11. Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion.
Storm FK; Sparks FC; Morton DL
Surg Gynecol Obstet; 1979 Jul; 149(1):17-21. PubMed ID: 451822
[TBL] [Abstract][Full Text] [Related]
12. Definition of unique and shared T-cell defined tumor antigens in human renal cell carcinoma.
Brouwenstijn N; Hoogstraten C; Verdegaal EM; Van der Spek CW; Deckers JG; Mulder A; Osanto S; Schrier PI
J Immunother; 1998 Nov; 21(6):427-34. PubMed ID: 9807737
[TBL] [Abstract][Full Text] [Related]
13. Bovine lactoferrin and Lactoferricin inhibit tumor metastasis in mice.
Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
Adv Exp Med Biol; 1998; 443():285-91. PubMed ID: 9781371
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of 5-fluorouracil microspheres on peritoneal carcinomatosis induced by Colon 26 or B-16 melanoma in mice.
Hagiwara A; Sakakura C; Shirasu M; Yamasaki J; Togawa T; Takahashi T; Muranishi S; Hyon S; Ikada Y
Anticancer Drugs; 1998 Mar; 9(3):287-9. PubMed ID: 9625440
[TBL] [Abstract][Full Text] [Related]
15. MMP-2 expression is associated with, but not sufficient for, malignant conversion of murine LTA cells.
Xuan JW; Tuck AB; Wilson SM; Chin JL; Chambers AF
Anticancer Res; 1998; 18(2A):743-9. PubMed ID: 9615714
[TBL] [Abstract][Full Text] [Related]
16. Cell differentiation and cell-cycle alterations by tyrosine kinase inhibitors in human melanoma cells.
Hartmann RR; Rimoldi D; Lejeune FJ; Carrel S
Melanoma Res; 1997 Aug; 7 Suppl 2():S27-33. PubMed ID: 9578414
[TBL] [Abstract][Full Text] [Related]
17. Human melanoma cell invasion: selected neurotrophin enhancement of invasion and heparanase activity.
Marchetti D; Nicolson GL
J Investig Dermatol Symp Proc; 1997 Aug; 2(1):99-105. PubMed ID: 9487024
[TBL] [Abstract][Full Text] [Related]
18. Favourable melanoma prognosis associated with the expression of the tumour necrosis factor receptor and the alpha1beta1 integrin: a preliminary report.
Gilhar A; Ullmann Y; Kalish RS; Berkutski T; Azizi E; Bank I
Melanoma Res; 1997 Dec; 7(6):486-95. PubMed ID: 9464621
[TBL] [Abstract][Full Text] [Related]
19. Enhanced anti-tumor effect of an IFN-gamma-EGF fusion protein.
Chen WQ; Ding YP; Zhang LL; Hou YD
Biomed Environ Sci; 1997 Dec; 10(4):387-95. PubMed ID: 9448920
[TBL] [Abstract][Full Text] [Related]
20. Recurrent melanoma of the leg and polypoid lesions of the gallbladder--a management dilemma.
Gould SW; Banwell PE; Rosin RD
Eur J Surg Oncol; 1997 Aug; 23(4):368-9. PubMed ID: 9315071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
